Chemicals
| Thu 25 Apr 2024
Alexandria, April 26 -- Celon Pharma SA has secured a patent on 3-phenyl-4-hexynoic acid derivatives as GPR40 agonists. Mach Mateusz, Dzida Radoslaw, Smuga Damian, Stelmach Filip, Matloka Mikolaj, Bazydlo Katarzyna, Dubiel Krzysztof, Wieczorek Maciej and Pieczykolan Jerzy developed the invention.
The patent application number..